Corcept Therapeutics (CORT) Tops Q4 EPS by 3c; Issues Light FY16 Revenue Outlook
Go back to Corcept Therapeutics (CORT) Tops Q4 EPS by 3c; Issues Light FY16 Revenue Outlook| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 116.27 +5.98 (5.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $110.29 | 52 Week High | $10.00 | |||
| Open | $110.29 | 52 Week Low | $3.22 | |||
| Day High | $116.55 | P/E | N/A | |||
| Day Low | $109.00 | EPS | $-0.46 | |||
| Volume | 383,214 | |||||
